| RS1595897345 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS1595898030 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595898055 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595898078 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595899478 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS1595900104 |
SLC51B
|
Health Risk |
Likely pathogenic |
Cholestasis, Diarrhea |
| RS1595902947 |
RAPSN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 11, Congenital myasthenic syndrome 11 |
| RS1595903667 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS1595904430 |
SIN3A
|
Health Risk |
Likely pathogenic |
— |
| RS1595907762 |
SIN3A
|
Health Risk |
Pathogenic |
— |
| RS1595908479 |
DMXL2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 81 |
| RS1595923494 |
KNL1
|
Health Risk |
Likely pathogenic |
— |
| RS1595928075 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1595935001 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595935759 |
BBS4
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1595938132 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595939517 |
TTC8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 8, Retinitis pigmentosa 51 |
| RS1595940058 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595940106 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595941653 |
SMAD3
|
Health Risk |
Pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1595941823 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1595941909 |
SMAD3
|
Health Risk |
Likely pathogenic |
— |
| RS1595942351 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1595945118 |
KNL1
|
Health Risk |
Likely pathogenic |
— |
| RS1595945569 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1595952313 |
DNAAF4;DNAAF4-CCPG1
|
Health Risk |
Likely pathogenic |
Dyslexia, susceptibility to |
| RS1595955503 |
DMXL2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 81 |
| RS1595956148 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS1595956416 |
SMAD3
|
Health Risk |
Pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1595956455 |
NR2E3
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1595956538 |
SMAD3
|
Health Risk |
Pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1595956573 |
SMAD3
|
Health Risk |
Likely pathogenic |
— |
| RS1595956595 |
NR2E3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1595956702 |
NR2E3
|
Health Risk |
Pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS1595956832 |
SMAD3
|
Health Risk |
Likely pathogenic |
Ascending aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1595957521 |
NR2E3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1595959305 |
TTC8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 8, Bardet-Biedl syndrome 8 |
| RS1595959849 |
DNAAF4
|
Health Risk |
Likely pathogenic |
— |
| RS1595960347 |
SMAD3
|
Health Risk |
Pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1595960447 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome |
| RS1595962708 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1595965925 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1595965945 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1595965957 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1595993043 |
ARNT2
|
Health Risk |
Likely pathogenic |
Webb-Dattani syndrome, Webb-Dattani syndrome |
| RS1596016716 |
DMXL2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 81 |
| RS1596017653 |
TRPM1
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS1596021185 |
ARNT2
|
Health Risk |
Pathogenic |
Webb-Dattani syndrome, Webb-Dattani syndrome |
| RS1596029830 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1596047883 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS1596048227 |
WDR73
|
Health Risk |
Conflicting classifications of pathogenicity |
Galloway-Mowat syndrome 1, Galloway-Mowat syndrome 1 |
| RS1596050243 |
WDR73
|
Health Risk |
Pathogenic |
— |
| RS1596050297 |
WDR73
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 1, Galloway-Mowat syndrome 1 |
| RS1596050386 |
WDR73
|
Health Risk |
Pathogenic |
Dystonic disorder, Dystonic disorder |
| RS1596050605 |
WDR73
|
Health Risk |
Pathogenic |
— |
| RS1596057578 |
WDR73
|
Health Risk |
Pathogenic |
Seizure, Dyskinesia |
| RS1596073421 |
CHRNA3
|
Health Risk |
Pathogenic |
Urinary bladder, atony of |
| RS1596088812 |
MAPKBP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis 20, Nephronophthisis 20 |
| RS1596106023 |
UBR1
|
Health Risk |
Pathogenic |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS1596118528 |
UBR1
|
Health Risk |
Pathogenic |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS1596128699 |
ACAN
|
Health Risk |
Likely pathogenic |
Osteochondritis dissecans, Osteochondritis dissecans |
| RS1596130811 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1596136784 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS1596144242 |
ACAN
|
Health Risk |
Pathogenic |
Osteochondritis dissecans, Osteochondritis dissecans |
| RS1596149339 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1596154534 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS1596155145 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS1596155634 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1596157044 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS1596158382 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS1596166524 |
AP3B2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1596182118 |
AP3B2
|
Health Risk |
Pathogenic |
— |
| RS1596183293 |
AP3B2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1596184582 |
RLBP1
|
Health Risk |
Pathogenic |
— |
| RS1596185276 |
RLBP1
|
Health Risk |
Pathogenic |
— |
| RS1596194950 |
DLL4
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 6, Adams-Oliver syndrome 6 |
| RS1596199137 |
HERC2
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS1596206474 |
UNC45A
|
Health Risk |
Likely pathogenic |
Osteootohepatoenteric syndrome, Osteootohepatoenteric syndrome |
| RS1596207451 |
HERC2
|
Health Risk |
Likely pathogenic |
Developmental delay with autism spectrum disorder and gait instability, Developmental delay with autism spectrum disorder and gait instability |
| RS1596214066 |
IGF1R
|
Health Risk |
Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596214576 |
IGF1R
|
Health Risk |
Pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596216178 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1596218041 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596218695 |
ETFA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1596218981 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1596219238 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596219393 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Bloom syndrome |
| RS1596219422 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596220242 |
NTHL1
|
Health Risk |
Likely pathogenic |
— |
| RS1596220332 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS1596220365 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596220478 |
NTHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS1596220502 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596221020 |
BLM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1596222596 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS1596222612 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596223211 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596223384 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS1596223715 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1596223773 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |